Patent 12016898 was granted and assigned to Amicrobe on June, 2024 by the United States Patent and Trademark Office.
Compositions comprising a mixture of an antimicrobial cationic polypeptide and a second pharmaceutically-acceptable polymer are disclosed, as well as methods and uses thereof for the treatment and prevention of infections that occur when our natural barriers of defense are broken.